ZIVALIO-M 500ER Tablets

For better Diabetic Outcomes

COMPOSITION – Zivalio-M 500 ER Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets

Category:

Description

>>Highly potent antihyperglycemic agent, beneficial for the treatment of type 2 diabetes (T2D).

>>Outstanding cardioprotective and renoprotective agent, an excellent option for patients with a history of cardiovascular and renal diseases. 

>Monotherapy as well as combination therapy provides effective glycaemic control, and reduces body weight and blood pressure (BP) across a broad spectrum of patients.

>>Co-administration of dapagliflozin and metformin has a valuable synergistic effect in maintaining blood sugar levels and reduces the incidence of hypoglycemia.

>>Highly effective in both early and late stages of T2DM, this helps in stopping the clinical progression of diabetes mellitus. 

Composition

Zivalio-M 500 ER Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets

Indications

  1. Diabetes mellitus
  2. Hypoglycemia
  3. Cardiovascular disorders
  4. Renal diseases